World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria

Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, HSF1-480, Baltimore, Maryland 21201, USA.
Malaria Journal (Impact Factor: 3.49). 02/2007; 6:121. DOI: 10.1186/1475-2875-6-121
Source: PubMed

ABSTRACT Molecular markers for drug resistant malaria represent public health tools of great but mostly unrealized potential value. A key reason for the failure of molecular resistance markers to live up to their potential is that data on the their prevalence is scattered in disparate databases with no linkage to the clinical, in vitro and pharmacokinetic data that are needed to relate the genetic data to relevant phenotypes. The ongoing replacement of older monotherapies for malaria by new, more effective combination therapies presents an opportunity to create an open access database that brings together standardized data on molecular markers of drug resistant malaria from around the world. This paper presents a rationale for creating a global database of molecular markers for drug resistant malaria and for linking it to similar databases containing results from clinical trials of drug efficacy, in vitro studies of drug susceptibility, and pharmacokinetic studies of antimalarial drugs, in a World Antimalarial Resistance Network (WARN). This database will be a global resource, guiding the selection of first line drugs for treating uncomplicated malaria, for preventing malaria in travelers and for intermittent preventive treatment of malaria in pregnant women, infants and other vulnerable groups. Perhaps most important, a global database for molecular markers of drug resistant malaria will accelerate the identification and validation of markers for resistance to artemisinin-based combination therapies and, thereby, potentially prolong the useful therapeutic lives of these important new drugs.

Download full-text


Available from: Christopher V Plowe, Aug 27, 2015
  • Source
    • "For example, chloroquine (CQ) resistance has been linked to a key mutation at position 76 of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene (Fidock et al., 2000). Standardized protocol for detection of the parasite mutations was planned to be a future tool for global mapping of anti-malarial drug resistance (Plowe et al., 2007). On the other hand, the major host factor that contributes to malaria TF is immunity (Djimde et al., 2003). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In malaria, drug resistance and treatment failure (TF) are not synonymous, although are escalating together. Over 9 years of surveillances for malaria morbidity and TF in Daraweesh village in eastern Sudan (1991-2004), 136 donors (15-78 years) from 43 households, treated for 278 malaria episodes and had experienced 46 incident of TF, were included in this study. Blood obtained from the donors in 2005, was used for measurement of IgG subclasses against Pf332-C231 antigen and GM/KM allotyping and for genotyping of the donors for; FcgammaRIIA 131 (HH, RH, RR), CRP 286 (C<T<A) and Hb AA/AS, polymorphisms. Results revealed that all treatment failures were experienced by 37 individual (TF-prone-individuals, TFPi), while the remaining donors were treated for 182 malaria episodes without TF (treatment responders, TR). In 7 households, all malaria patients were TFPi, while in 19 households all patients were TR. The TFPi compared with matched TR individuals (TRi), had significantly higher IgG1 levels (p=0.021), while IgG3/IgG1 ratio was significantly higher in the TRi (p=0.016). However, the frequencies of all tested polymorphisms (GM/KM, FcgammaRIIA 131, CRP 286 and Hb AA/AS), were comparable between the study groups. In conclusion, there was clustering of TF at level of individuals and households with differences in base-line immunity between the TFPi and TRi. Together, the results suggest an immune-mediated genetic susceptibility to TF, as some of the tested polymorphisms showed trends but no significant association with TF.
    Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases 03/2010; 10(4):481-6. DOI:10.1016/j.meegid.2010.02.013 · 3.26 Impact Factor
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Rheumatoid arthritis is a chronic inflammatory disease affecting synovial joints of the body, especially the hands and feet, spine, knees and hips. For many patients, the cervical spine is associated with rheumatoid arthritis. Subluxation is the abnormal movement of one of the bones that comprise a joint. In this research, image analysis techniques have been investigated for the recognition of cervical spine x-ray images with one or more instances of subaxial subluxation. Receiver operating characteristic curve results are presented, showing potential for subaxial subluxation discrimination on an image-by-image basis.
    17th IEEE Symposium on Computer-Based Medical Systems (CBMS 2004), 24-25 June 2004, Bethesda, MD, USA; 01/2004
Show more